Cochrane COVID-19 Studienregister
Studienbericht
NCT05043285Erstmals veröffentlicht: 2021 Sept 14Letzte Aktualisierung: 2021 Sept 14

A Randomized, Double-blinded, Placebo-controlled Phase I/II/III Clinical Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Protective Efficacy of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated Vaccine Against COVID-19 Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated Vaccine Against COVID-19

  1. Studientyp
  2. Interventional
  1. Studienziel
  2. Prevention
  1. Studiendesign
  2. Parallel/Crossover
  1. Interventionszuordnung
  2. Randomised
Referenzdatensätze

TThe Safety and Efficacy of SCTV01C in Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine

Sinocelltech Ltd.
Erstmals veröffentlicht (first received 2021 September 14)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05043285)
Eintrag in Studienregister
Keine Ergebnisse
The objective of this study is to evaluate the safety, tolerability, immunogenicity, and protective efficacy of SCTV01C in healthy population aged ≥18 years previously vaccinated with inactivated COVID-19 vaccine